title: [Clinical aspects of brain metastases from nasopharyngeal carcinoma].
abstract: Metastasis to the central nervous system, either through a hematogenous route or through the cerebrospinal fluid, is extremely rare in nasopharynx cancer. We aim to expose clinical aspects, therapeutic features and prognosis of nasopharyngeal carcinoma with brain metastases. We retrospectively reviewed the medical history of about 420 patients with nasopharyngeal carcinoma treated during 17 years at the university hospital of Sfax (Tunisia). Among them, three patients had brain metastasis. We excluded patients with direct extension to the brain. Tumours of the nasopharynx were locally advanced. The first patient had brain metastases at the initial diagnosis. The two other patients had brain metastases at 10 and 16 months during the follow-up. Ocular signs were the symptoms. Lesions were unique in two patients. Synchronous bone metastases were recorded in the three cases. All patients had whole brain radiation therapy and palliative chemotherapy. All patients had a progression of the disease and died. Brain metastases in nasopharynx cancer represent a rare event. Prognosis is poor, depending on age, surgical excision and synchronous metastases. Survival does not exceed 6 months.
authors.affiliation: Service de radiothérapie carcinologique, CHU Habib Bourguiba, Sfax, Tunisie. Electronic address: fatma.elloumi@yahoo.fr.
authors.forename: F
authors.initials: F
authors.lastname: Elloumi
authors.forename: M
authors.initials: M
authors.lastname: Ben Amor
authors.forename: L
authors.initials: L
authors.lastname: Ghorbel
authors.forename: H
authors.initials: H
authors.lastname: Mnif
authors.forename: T
authors.initials: T
authors.lastname: Boudawara
authors.forename: A M
authors.initials: AM
authors.lastname: Ghorbel
authors.forename: M
authors.initials: M
authors.lastname: Frikha
authors.forename: J
authors.initials: J
authors.lastname: Daoud
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D001932:Brain Neoplasms / Q000556:secondary* / Q000628:therapy; D002277:Carcinoma / Q000473:pathology* / Q000556:secondary* / Q000628:therapy; D059248:Chemoradiotherapy; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000473:pathology* / Q000628:therapy; D020360:Neoadjuvant Therapy; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents
keywords: Brain; Carcinoma; Carcinome; Cerveau; Metastasis; Métastase; Nasopharynx